Hardik Parikh
Stock Analyst at J.P. Morgan
(0.30)
# 4,150
Out of 4,386 analysts
24
Total ratings
33.3%
Success rate
-16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Hardik Parikh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KLRA Kailera Therapeutics | Initiated Coverage: Buy | $30 | $19.70 | +52.28% | 1 | May 12, 2026 | |
| PCRX Pacira BioSciences | Maintained: Sell | $23 | $22.86 | +0.61% | 11 | Mar 20, 2026 | |
| GPCR Structure Therapeutics | Maintained: Buy | n/a | $37.77 | - | 5 | Mar 16, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | $75 | $29.24 | +156.50% | 7 | Feb 11, 2026 |
Kailera Therapeutics
May 12, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $19.70
Upside: +52.28%
Pacira BioSciences
Mar 20, 2026
Maintained: Sell
Price Target: $23
Current: $22.86
Upside: +0.61%
Structure Therapeutics
Mar 16, 2026
Maintained: Buy
Price Target: n/a
Current: $37.77
Upside: -
Viking Therapeutics
Feb 11, 2026
Maintained: Buy
Price Target: $75
Current: $29.24
Upside: +156.50%